雷替曲塞在实体肿瘤中应用的研究进展

doi:10.11904/j.issn.1002-3070.2015.03.018

实用肿瘤学杂志 ›› 2015, Vol. 29 ›› Issue (3): 271-274.doi: 10.11904/j.issn.1002-3070.2015.03.018

雷替曲塞在实体肿瘤中应用的研究进展

赵洪伟综述, 张玉宝审校

哈尔滨医科大学附属肿瘤医院肝胆胰外科(哈尔滨 150081)

收稿日期:2014-10-25 出版日期:2015-06-28 发布日期:2015-06-25
通讯作者: 张玉宝 E-mail:zhyb88077@sina.com
作者简介:赵洪伟,男,(1987-),硕士研究生,从事肝胆胰肿瘤的研究

The progression on exploratory development of raltitrexed in solid tumors

ZHAO Hongwei,ZHANG Yubao

Department of Hepatobiliary and Pancreatic Surgery,The Affiliated Tumor Hospital of Harbin Medical University,Harbin 150081,China

Received:2014-10-25 Online:2015-06-28 Published:2015-06-25

摘要/Abstract

摘要：

雷替曲塞单独或联合其他抗癌药物在各种实体肿瘤化疗中能够起到较好的作用。本文分析了近年来国内、外有关雷替曲塞在各种实体肿瘤中的研究进展,探索其抗肿瘤的作用和机制。雷替曲塞是一种具有良好抗癌作用的药物,随着研究的深入,将会在实体肿瘤的治疗中发挥更大的作用。

关键词: 雷替曲塞, 胸苷酸合酶抑制剂, 实体肿瘤

Abstract:

The single or combined administration of Raltitrexed with other anticancer drugs have showed prospective curative effects on solid tumor.This paper reviews the current research situation of Raltitrexed against malignant tumor and explores the possibilities for the efficacy and mechanism in treatment of malignant tumor.Raltitrexed is one kind of effective anti cancer drugs and plays a more and more important role in solid tumor therapy.

Key words: Raltitrexed, TS inhibitor, Solid tumor

中图分类号:

R735

赵洪伟综述, 张玉宝审校. 雷替曲塞在实体肿瘤中应用的研究进展[J]. 实用肿瘤学杂志, 2015, 29(3): 271-274.

ZHAO Hongwei,ZHANG Yubao. The progression on exploratory development of raltitrexed in solid tumors[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 271-274.

参考文献

1 Hagner N,Joerger M.Cancer chemotherapy:targeting folic acid synthesis[J].Cancer Manag Res,2010,19(5):293-301.
2 吴杨佳子,高玉艳,张艳桥.精氨酸酶在结直肠癌中的研究进展[J].实用肿瘤学杂志,2013,27(5):460-462.
3 Van CE,Oliveirea J.ESMO Guidelines Working Group.Advanced colorectal cancer:ESMO clinical recommendations for diagnosis,treatment and follow-up[J].Ann Oncol,2009,20(4):61-65.
4 Barni S,Ghidini A,Coinu A,et al.A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancer[J].Anticancer Drugs,2014,25(10):1122-1128.
5 Liu Y,Wu W,Hong W,et al.Raltitrexed-based chemotherapy for advanced colorectal cancer[J].Clin Res Hepatol Gastroenterol,2014,38(2):219-225.
6 Bozkurt O,Karaca H,Ciltas A,et al.Efficacy and safety of raltitrexed combinations with uracil-tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients:a multicenter study of anatolian society of medical oncology(ASMO)[J].Asian Pac J Cancer Prev,2014,15(4):1845-1849.
7 王佳蕾,李进,刘天舒,等.雷替曲塞或5-FU/CF联合奥沙利铂治疗局部晚期或复发转移性结直肠癌多中心、随机、对照Ⅲ期临床试验[C].北京:第十届全国临床肿瘤学大会暨2007年CSCO学术年会中国临床肿瘤学教育专辑,2007:335-340.
8 Kim GP,Sargent DJ,Mahoney MR,et al.Phase III noninferiority trial comparing irinotecan with oxaliplatin,fluorouracil,and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil:N9841[J].J Clin Oncol,2009,27(17):2848-2854.
9 Shen J,Wang H,Wei J,et al.Thymidylate synthase mRNA levels in plasma and tumor as potential predictive biomarkers for raltitrexed sensitivity in gastric cancer[J].Int J Cancer,2012,131(6):938-945.
10 孙静,胜照杰.雷替曲塞联合多西他赛治疗进展期胃癌的临床观察[J].现代中西医结合杂志,2013,22(22):2435-2438.
11 Wei J,Costa C,Ding Y,et al.mRNA expression of BRCA1,PIAS1,and PIAS4 and survival after second-line docetaxel in advanced gastric cancer[J].J Natl Cancer Inst,2011,103(20):1552-1556.
12 Wesolowski R,Lee C,Kim R.Is there a role for second-line chemotherapy in advanced gastric cancer?[J].Lancet Oncol,2009,10(9):903-912.
13 岳顺,张大红,周磊磊.雷替曲塞联合多西他赛治疗晚期胃癌的临床疗效[J].肿瘤防治研究,2014,41(2):160-162.
14 王咏梅,王革芳,吴成利,等.雷替曲塞等化疗药物低剂量动脉灌注治疗胃癌术后并发恶性肠梗阻[J].实用临床医药杂志,2012,16(13):18-22.
15 Cowley MJ,Chang DK,Pajic M,et al.Understanding pancreatic cancer genomes[J].J Hepatobiliary Pancreat Sci,2013,20(6):549-556.
16 Kedia P,Gaidhane M,Kahaleh M.Technical Advances in Endoscopic Ultrasound(EUS)-Guided Tissue Acquisition for Pancreatic Cancers:How Can We Get the Best Results with EUS-Guided Fine Needle Aspiration?[J].Clin Endosc,2013,46(5):552-562.
17 Francois E,Hebbar M,Bennouna J,et al.A phase II trial of raltitrexed(Tomudex)in advanced pancreatic and biliary carcinoma[J].Oncology,2005,68(4-6):299-305.
18 Arends JJ,Sleeboom HP,Leys MB,et al.A phase II study ofraltitrexed and gemcitabine in patients with advanced pancreatic carcinoma[J].Br J Cancer,2005,92(3):445-448.
19 Reni M,Pasetto L,Aprile G,et al.Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer[J].Br J Cancer,2006,94(6):785-791.
20 孙静,胜照杰,郭君兰.雷替曲塞联合顺铂治疗进展期食管癌疗效观察[J].现代中西医结合杂志,2014,23(27):2989-2997.
21 夏铀铀,王磊,宋大安,等.放疗联合雷替曲塞奥沙利铂同步治疗晚期食管癌的Ⅱ期临床研究[J].中国肿瘤床,2014,41(11):716-719.
22 Bottomley A,Gaafar R,Manegold C,et al.Short-term treatment-related symptoms and quality of life:results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma:an EORTC Lung-Cancer Group and National Cancer Institute,Canada,Intergroup Study [J].J Clin Oncol,2006,24(9):1435-1442.
23 迟洪亮.奈达铂联合雷替曲塞治疗晚期喉咽癌17例分析[J].中国医药指南,2014,12(19):199-200.
24 Galetta D,Giotta F,Rosati G,et al.Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cellcarcinoma[J].Anticancer Res,2005,25(7):4445-4449.
25 刘佳,白玉贤.晚期原发性肝癌的全身化疗及靶向治疗[J].实用肿瘤学杂志,2013,27(1):88-92.
26 梁君,陈元龙,潘辉娟,等.以雷替曲塞为基础经动脉灌注化疗的安全性和有效性分析[J].影像诊断与介入放射学,2013,22(6):436-438
27 韩啸,张竞竞,王洪亚,等.雷替曲塞或氟尿嘧啶联合吉西他滨治疗晚期乳腺癌的疗效比较[J].蚌埠医学院报,2013,38(8):946-950.
28 Li XY,Liu L,Xie XM,et al.The role ofraltitrexed/cisplatin with concurrent radiation therapyin treating advanced cervical cancer[J].Eur Rev Med Pharmacol Sci,2014,18(22):3491-3496.

雷替曲塞在实体肿瘤中应用的研究进展

The progression on exploratory development of raltitrexed in solid tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价